Ticker League

Spruce Biosciences (SPRB) Profit Bridge

See what drove Spruce Biosciences's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

TTM

Revenue YoY

Operating Income YoY

+41.38%

Net Income YoY

+32.90%

Net Margin Δ

Net income bridge for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $18.26M+32.90%

Profit bridge breakdown for Spruce Biosciences (SPRB) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income−$55.45M
  • Revenue−$2.91M
  • Cost of Revenue$0.00
  • Operating Expenses$26.91M
  • Other Income / Expense−$5.74M
  • Income Tax$0.00
  • Net Loss−$37.19M
Identity check: drivers reconcile to ΔNI within $0.00
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation